Details for New Drug Application (NDA): 074425
✉ Email this page to a colleague
NDA 074425 describes PENTOXIFYLLINE, which is a drug marketed by Ani Pharms, Apotex, Bausch, Heritage, Impax Labs, Pliva, and Rising, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the PENTOXIFYLLINE profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 074425
| Tradename: | PENTOXIFYLLINE |
| Applicant: | Rising |
| Ingredient: | pentoxifylline |
| Patents: | 0 |
Pharmacology for NDA: 074425
| Physiological Effect | Hematologic Activity Alteration |
Medical Subject Heading (MeSH) Categories for 074425
Suppliers and Packaging for NDA: 074425
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074425 | ANDA | Rising Pharma Holdings, Inc. | 16571-856 | 16571-856-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01) |
| PENTOXIFYLLINE | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074425 | ANDA | Rising Pharma Holdings, Inc. | 16571-856 | 16571-856-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
| Approval Date: | Jul 8, 1997 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
